Serenus Global
  • Home
  • Divisions
    • Psychedelics Division
    • Cannabis Division
  • Why Serenus
  • Shop
  • News
  • Contact Us
  • Investors
    • Investor Overview
    • Press Releases
    • Latest Presentation
    • Management Team
    • Corporate Charters
  • News
  • Shop
  • Contact Us
Select Page
Psilocybin-enhanced group psychotherapy for depression shows promise in patients with cancer

Psilocybin-enhanced group psychotherapy for depression shows promise in patients with cancer

Jun 20, 2023 | Psychedelics

Psilocybin-enhanced group psychotherapy for depression shows promise in patients with cancer A new study suggests that psilocybin-assisted group therapy is a promising approach for cancer patients dealing with depressive symptoms. The research, which appears in the...
Psychedelic drugs reopen ‘critical periods’ for social learning

Psychedelic drugs reopen ‘critical periods’ for social learning

Jun 14, 2023 | Psychedelics

Psychedelic drugs reopen ‘critical periods’ for social learning Neuroscientists have long searched for ways to reopen “critical periods” in the brain, when mammals are more sensitive to signals from their surroundings that can influence periods...
Next Entries »
Email Alerts Shop Products

NEWSLETTER SIGNUP

NEWS

  • Company News
  • Industry News
  • Email Alerts

DIVISIONS

  • Psychedelics
  • Cannabis

INVESTORS

  • Press Releases
  • Latest Presentation
  • Board of Directors
  • Corporate Charters

COMPANY

  • Why Serenus
  • Management Team
  • Contact Us
  • FAQ’s
  • Facebook
  • Twitter
  • Instagram
© Copyright 2023 Serenus Global. All rights reserved.
Privacy PolicyTerms and Conditions